The two organizations are joining forces to maximize the human and economic benefits of clinical trials province-wide.
Novartis and Roche Join the CATALIS Initiative Industry partnership will help establish Quebec as a global leader in early stage clinical research MONTREAL, February 6, 2019— The CATALIS initiative is proud to announce that pharmaceutical companies Novartis and Roche have joined its partner network. A mere two years after its creation, CATALIS Québec has succeeded in mobilizing Quebec’s key players
The CATALIS initiative celebrates new partners Private and public funding provide essential support and highlight Quebec’s role in the field of early stage clinical trials BOSTON, June 5th, 2018 – A year following its launch at the BIO conference in 2017, the CATALIS initiative is today proud to announce the arrival of new partners, both financial and medical, which will further
Progression of Quebec’s world-class Early Clinical Research Ecosystem Merck Canada provides financial and expert support to CATALIS MONTREAL, Quebec (May 9, 2018) – CATALIS is proud to announce that Merck Canada confirms financial and expert support for its early clinical research initiative. This support from Merck Canada contributes to the promotion of this world-class field of research in Quebec. “At